Allogeneic Versus Autologous Bone Marrow Transplantation for Refractory and Recurrent Low-Grade Non-Hodgkin's Lymphoma: Updated Results of the Utrecht Experience

References

• Young R. C., Longo D. L., Glatstein E., Ihde B. C., Jaffe E. S., DeVita V. T. The treatment of indolent lymphomas: watchful waiting Vaggressive combined modality treatment. Sem Hematol 1988; 25: 11–16
   PubMed Web of Science ®Google Scholar
• Horning S. J. Natural history of and therapy for the indolent non-Hodgkin's lymphoma. Sem Oncol 1993; 20: 75–88
   PubMed Web of Science ®Google Scholar
• Cheson B. D. New chemotherapeutic agents for the treatment of low-grade non-Hodgkin's lymphomas. Sem Oncol 1993; 20: 96–110
   PubMed Web of Science ®Google Scholar
• Horning S. J. Treatment approaches to the low-grade lymphomas. Blood 1994; 83: 881–884
   PubMed Web of Science ®Google Scholar
• Hagenbeek A., Card P., Meerwaldt J. H., Somers R., Thomas J., De Bock R., Raemakers J. M.M., Van Hoof A., De Wolf-Peeters C., Van Glabbeke M. Maintenance of remission with human recombinant interferon alfa-2a in patients with stages III and IV low-grade malignant non-Hodgkin's lymphoma. J Clin Oncol 1998; 16: 41–47
   PubMed Web of Science ®Google Scholar
• Arranz R., Garcia-Alfonso P., Sobrino P., Zamora P., Carrion R., Garcia-Larana J. G., Perez G., Lopez J., Lavilla E., Lozano M., Rayon C., Colomer, Gonzalez R., Baron M., Flores E., Perez-Manga G., Fernandez-Rananda J. M. Role of interferon alfa2b in the induction and maintenance treatment of low-grade non-Hodgkin's lymphoma: results from a prospective, multicenter trail with double randomization. J Clin Oncol 1998; 16: 1538–1546
   PubMed Web of Science ®Google Scholar
• Weisdorf D. J., Andersen J. W., Glick J. H., Oken M. M. Survival after relapse of low-grade non-Hodgkin's lymphoma: implications for marrow transplantation. J Clin Oncol 1992; 10: 942–947
   PubMed Web of Science ®Google Scholar
• Johnson P. W.M., Rohatiner A. Z.S., Whelan J. S., Price C. G.A., Love S. L., Matthews J., Norton A. J., Amess J. A.L., Lister T. A. J Clin Oncol 1995; 13: 140–147
   PubMed Web of Science ®Google Scholar
• Armitage J. O. Bone marrow transplantation for indolent lymphomas. Sem Oncol 1993; 20: 136–142
   PubMed Web of Science ®Google Scholar
• Rohatiner A. Z.S., Johnson P. W.M., Price C. G.A., Arnott S. J., Amess J. A.L., Norton A. J., Dorey E., Adams K., Whelan J. S., Matthews J., MacCallum P. K., Oza A. M., Lister T. A. Myeloablative therapy with autologous bone marrow transplantation as consolidation therapy for recurrent follicular lymphoma. J Clin Oncol 1994; 12: 1177–1184
   PubMed Web of Science ®Google Scholar
• Schouten H. C., Colombat Ph., Verdonck L. F., Gorin N. C., Björkstrand B., Taghipour G., Goldstone A. H. Autologous bone marrow transplantation for low-grade non-Hodgkin's lymphoma: the European Bone Marrow Transplant Group experience. Ann Oncol 1994; 5: S147–S149
   PubMed Web of Science ®Google Scholar
• Nademanee A., Sniecinski I., Schmidt G. M., Dagis A. C., O'Donnell M. R., Snyder D. S., Parker P. M., Stein A. S., Smith E. P., Molina A., Stepan D. E., Somlo G., Margolin K. A., Woo D., Niland J. C., Forman S. J. High-dose therapy followed by autologous peripheral blood stem cell transplantation for patients with Hodgkin's disease and non-Hodgkin's lymphoma using unprimed and granulocyte colony stimulating factor mobilized peripheral blood stem cells. J Clin Oncol 1994; 12: 2176–2186
   PubMed Web of Science ®Google Scholar
• Bastion Y., Brice P., Haioun C., Sonet A., Salles G., Marolleau J. P., Espinouse D., Reyes F., Gisselbrecht C., Coiffier B. Intensive therapy with peripheral blood progenitor cell transplantation in 60 patients with poor-prognosis follicular lymphoma. Blood 1995; 86: 3257–3262
   PubMed Web of Science ®Google Scholar
• Freedman A. S., Gribben J. G., Neuberg D., Mauch P., Soiffer R. J., Anderson K. C., Pandite L., Robertson M. J., Kroon M., Ritz J., Nadler L. M. High-dose therapy and autologous bone marrow transplantation in patients with follicular lymphoma during first remission. Blood 1996; 88: 2780–2786
   PubMed Web of Science ®Google Scholar
• Bierman P. J., Vose J. M., Anderson J. R., Bishop M. R., Kessinger A., Armitage J. O. High-dose therapy with autologous hematopoietic rescue for follicular low-grade non-Hodgkin's lymphoma. J Clin Oncol 1997; 15: 445–450
   PubMed Web of Science ®Google Scholar
• Van Besien K. W., Khouri I. F., Giralt S. A., McCarthy P., Mehra R., Andersson B. S., Przepiorka D., Gajewski J. L., Bellare N., Nath R., Romaguera J. F., McLaughlin P., Korbling M., Deisseroth A. B., Cabanillas F. F., Champlin R. E. Allogeneic bone marrow transplantation for refractory and recurrent low-grade lymphoma: the case for aggressive management. J Clin Oncol 1995; 13: 1096–1102
   PubMed Web of Science ®Google Scholar
• Verdonck L. F., Dekker A. D., Lokhorst H. M., Petersen E. J., Nieuwenhuis H. K. Allogeneic versus autologousbone marrow transplantation for refractory and recurrent low-grade non-Hodgkin's lymphoma. Blood 1997; 90: 4201–4205
   PubMed Web of Science ®Google Scholar
• Verdonck L. F., Dekker A. W., De Gast G. C., Van Kempen M. L., Lokhorst H. M., Nieuwenhuis H. K. Allogeneic bone marrow transplantation with a fixed low number of T cells in the marrow graft. Blood 1994; 83: 3090–3096
   PubMed Web of Science ®Google Scholar
• Verdonck L. F., Dekker A. W., Van Kempen M. L., Punt K., Van Unnik J. A.M., Van Peperzeel H. A., Gast G. C. de. Intensive cytotoxic therapy followed by autologous bone marrow transplantation for non-Hodgkin's lymphoma of high-grade malignancy. Blood 1985; 65: 984–989
   PubMed Web of Science ®Google Scholar
• Thomas E. D., Storb R., Clift R. A., Fefer M., Johnson F. L., Neiman P. F., Lerner K. G., Glucksberg H., Buckner C. D. Bone marrow transplantation. N Engl J Med 1975; 292: 895–902
   PubMed Web of Science ®Google Scholar
• Attal M., Socie G., Molina L., Jouet J. P., Kuentz M., Blaise D., Milpied N., Ifrah N., Payen C., Tanguy M. L. Allogeneic bone marrow transplantation for refractory and recurrent follicular lymphoma: a case-matched analysis with autologous transplantation from the french bone marrow transplant group registry data. Blood 1997; 90, (suppl 1), Abstract 1120
   Google Scholar
• Van Besien K., Rowlings P. A., Sobocinski K. A., Phillips G., Vose J., McCarthy P., Klein J. P., Champlin R., Horowitz M. M. Allogeneic bone marrow transplantation for low grade lymphoma. Blood 1995; 86, (suppl 1), Abstract 824
   Google Scholar
• Mandigers C. M.P.W., Raemaekers J. M.M., Schattenberg A. V.M.B., Roovers E. A., Bogman M. J.J.T., Van der Maazen R. W.M., De Pauw D. E., De Witte T. Allogeneic bone marrow transplantation with T-cell-depleted marrow grafts for patients with poor-risk relapsed low-grade non Hodgkin's Lymphoma. Br J Haemat 1998; 100: 198–206
   PubMed Web of Science ®Google Scholar
• Cartwright R. A., McKinney P. A., Barnes N. Epidemiology of the lymphomas in the United Kingdom: recent developments. Baillière's Clinical Haematology, T. J. McElwain, T. A. Lister. Baillière Tindall, London 1987; 59–76
   Google Scholar